These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 35664644

  • 1. A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.
    Qing X, Liu L, Mao X.
    Comput Math Methods Med; 2022; 2022():9339325. PubMed ID: 35664644
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M.
    BMC Cancer; 2012 Jun 19; 12():258. PubMed ID: 22712526
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis.
    Olsen M, Lof P, Stiekema A, van den Broek D, Wilthagen EA, Bossuyt PM, Lok CAR.
    Acta Obstet Gynecol Scand; 2021 Oct 19; 100(10):1788-1799. PubMed ID: 34212386
    [Abstract] [Full Text] [Related]

  • 5. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
    Huang GQ, Xi YY, Zhang CJ, Jiang X.
    Genet Test Mol Biomarkers; 2019 Aug 19; 23(8):580-588. PubMed ID: 31373853
    [Abstract] [Full Text] [Related]

  • 6. Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer.
    Zhang P, Wang C, Cheng L, Zhang P, Guo L, Liu W, Zhang Z, Huang Y, Ou Q, Wen X, Tian Y.
    Medicine (Baltimore); 2015 Dec 19; 94(52):e2402. PubMed ID: 26717395
    [Abstract] [Full Text] [Related]

  • 7. The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
    Sun J, Cui XW, Li YS, Wang SY, Yin Q, Wang XN, Gu L.
    Eur Rev Med Pharmacol Sci; 2020 Jul 19; 24(13):7276-7283. PubMed ID: 32706065
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
    Ahmed AA, Abdou AM.
    Curr Probl Cancer; 2019 Oct 19; 43(5):450-460. PubMed ID: 30670303
    [Abstract] [Full Text] [Related]

  • 9. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125.
    Li W, Wang D.
    Arch Gynecol Obstet; 2020 May 19; 301(5):1219-1225. PubMed ID: 32266526
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic value of CA125, HE4 and Copenhagen Index in differentiating benign from malignant epithelial ovarian tumors].
    Gong SP, Chen YN, Zhang YD, Yao W, Chen L, Liu SS, Wu H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May 20; 37(5):628-632. PubMed ID: 28539285
    [Abstract] [Full Text] [Related]

  • 11. The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis.
    Li Y, Wang ZC, Luo L, Mu CY, Xu J, Feng Q, Li SB, Gu B, Ma P, Lan T.
    Eur Rev Med Pharmacol Sci; 2020 Jan 20; 24(2):604-610. PubMed ID: 32016961
    [Abstract] [Full Text] [Related]

  • 12. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P, Åkesson A, Hedenfalk I, Malander S, Borgfeldt C.
    PLoS One; 2020 Jan 20; 15(10):e0240418. PubMed ID: 33075095
    [Abstract] [Full Text] [Related]

  • 13. HE4 combined with CA125: favorable screening tool for ovarian cancer.
    Ghasemi N, Ghobadzadeh S, Zahraei M, Mohammadpour H, Bahrami S, Ganje MB, Rajabi S.
    Med Oncol; 2014 Jan 20; 31(1):808. PubMed ID: 24323399
    [Abstract] [Full Text] [Related]

  • 14. Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer.
    Xi QP, Pu DH, Lu WN.
    Eur Rev Med Pharmacol Sci; 2017 Oct 20; 21(20):4536-4541. PubMed ID: 29131263
    [Abstract] [Full Text] [Related]

  • 15. HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer.
    Ortiz-Muñoz B, Aznar-Oroval E, García García A, Covisa Peris A, Perez Ballestero P, Sanchez Yepes M, Garcia Lozano T, Illueca Ballester C, García Garcia E.
    Tumour Biol; 2014 Jul 20; 35(7):7249-58. PubMed ID: 24771264
    [Abstract] [Full Text] [Related]

  • 16. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
    Nyangoh-Timoh K, Bendifallah S, Dion L, Ouldamer L, Levêque J.
    Gynecol Obstet Fertil Senol; 2020 Mar 20; 48(3):277-286. PubMed ID: 32004789
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis.
    Wang J, Gao J, Yao H, Wu Z, Wang M, Qi J.
    Tumour Biol; 2014 Jun 20; 35(6):6127-38. PubMed ID: 24627132
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.